Coulter Partners conducts successful Chair search for Coramaze Technologies

Coramaze Technologies is a pre-commercial medical technology company, focused on developing a novel tricuspid valve repair system, called Tripair™, a minimally invasive solution for treating tricuspid regurgitation (TR). Tripair™ simplifies TR repair through an innovative transcatheter edge-to-spacer approach, aiming to reduce procedural complexity and improve access to care.

MTIP, a Swiss-based growth equity and buyout firm, has been a committed partner to Coramaze since 2017, supporting its journey from early innovation to a breakthrough in tricuspid regurgitation treatment.

Rob ten Hoedt, a respected leader in the medical technology industry, joins Coramaze with a proven track record, including his roles as Executive Vice-President and President of Global Regions at Medtronic and Chair of MedTech Europe. He currently serves as Chair of the Board at ONWARD Medical.

A former Executive Committee Member at Medtronic, Ten Hoedt brings extensive global experience in medical technology innovation and strategic business growth. This expertise will be invaluable as Coramaze advances its groundbreaking Tripair Technology. His guidance will be crucial in navigating the transition from global feasibility studies to pivotal clinical trials, and ultimately, the commercialization and global market entry of Tripair.

"We are honored to welcome Rob as our Chair," commented Jochen Reinöhl, CEO of Coramaze Technologies. "His strategic insights, deep industry expertise, and track record in building and scaling transformative technologies align perfectly with our mission. Rob’s appointment marks a significant milestone for Coramaze and reinforces the promise of Tripair™ as a game-changing therapy for tricuspid regurgitation."

Jochen Reinöhl continued, “Rob's appointment concludes a rigorous executive search process that MTIP initiated in collaboration with Coulter Partners. Their deep understanding of the transatlantic talent pool, coupled with their extensive personal connections, proved invaluable in our search for a new Chair. Their ability to leverage their network and foster a close relationship with both our investors and our company – building on my previous placement as CEO – demonstrated a level of partnership we truly appreciate. We look forward to continuing this fruitful collaboration."

----

Rob ten Hoedt, Chair of Board of Directors at Coramaze Technologies

Rob ten Hoedt’s extensive career in Medtech includes serving as Executive Vice President & President at Medtronic until August 2024, where he oversaw commercial operations in EMEA, Asia-Pacific, the USA, Canada and Latin America. He was a member of Medtronic’s Executive Committee and chaired the Board of MedTech Europe from 2014 to 2022. Joining Medtronic in 1991, he progressed through various regional and business leadership roles, including Executive Vice President & President, EMEA (later expanded to include APAC). Prior to Medtronic, Rob worked in several medical technology companies including Arjo Hospital Equipment and Polystan Benelux and also ran his own medical equipment distribution company. Rob graduated with a degree in Commercial Economy from the H.E.A.O., the Netherlands, and holds a Master’s in Marketing from the NIMA Business School.

About Coramaze Technologies

About Coulter Partners